LCN2 and ovarian cancer: In the same study, Lim and collaborators analyzed NGAL in ovarian cancer cell lines treated with epidermal growth factor (EGF) indicating that NGAL expression was downregulated in ovarian cancer cell lines undergoing the epithelial to mesenchymal transition (EMT) induced by EGF.